Loading...
Symbols:
Loading...
Symbols:
Abbott Laboratories (ABT)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Abbott Laboratories (ABT)
121 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on ABT
- SA Editor Miriam Metzinger(12)
- Mike Havrilla(9)
- Mike Huckman(8)
- Centient Biotech Investor(7)
- SA Editor Eli Hoffmann(6)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(529)
- SA Editor Eli Hoffmann(379)
- Dividends4Life (217)
- Stockerblog (156)
- SA Editor Joan Wickham(144)
Most commented on authors
- Mike Havrilla(28)
- Mark Perry(21)
- David Van Knapp(20)
- Dividends4Life (17)
- SA Editor Joan Wickham(16)
- 5 Health Care Stocks for Value Investors
- Health Innovator's Index: Does R&D Lead to Higher Stock Prices?
- General Electric Moves On Down the Largest Company List
- Who Will Take GM's Place in the Dow?
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Highly Defensive ETFI: Lower Volatility, Higher Returns
- ETFI Global Healthcare Sector PerfomIdex
- 'Great' Companies That Are, Literally, Good to Go
- S&P 500 Stocks Furthest Above and Below Consensus Price Targets
- Winners and Losers in a Democratic Administration
- Healthcare, Energy Sectors Shouldn't Fear Obama
- FDA Watch: Painkillers on the Fall/Winter Agenda
- Volatile Range Trading - Fast Money Recap (10/16/08)
- Three Reasons for Bear - Fast Money Recap (10/15/08)
- Ten Illinois Stocks
- Earnings Preview: Abbott Labs
- Johnson & Johnson Earnings Makes Dollars and Stents
- Getting Beyond the Fear Itself
- Dividend Aristocrats Survived September
- Pharmaceuticals: Pfizer Is a Buy
- A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.
- Biotech Names With Big Potential
- Being Short New York - Fast Money Recap (9/22/08)
- Abbott, Boston Scientific: Rising Stent Stars
- Which Company Should Replace AIG in the Dow?
- Summer Surge for Pharma Powers IHE, but Concerns Remain
- Yangtze River Delta Developing Huge R&D Base for Drug Companies
- Why Dividend Investors View Stocks Differently
- Dividend Aristocrats Handily Outperforming Main Indexes in 2008
- 15 Value Hedge Funds - Portfolio Update
- Abbott Labs Beefs Up Its Drug Portfolio and Stent Business
- Companies With Recent, Innovative Product Approvals vs. Healthcare ETFs
- PowerShares FTSE RAFI Healthcare: Big Bets on Dow Dogs
- Abbott Laboratories: The Choice Within Big Pharma
- The State of Statins and Stents
- The Long Case for Abbott Laboratories
- Just What the Doctor Ordered: Comparing the Pharma ETFs
- Abbott: Too Overvalued to Make a Good Dividend Investment?
- Abbott Proves Successful in a Very Tough Market
- Abbott Labs Reports Stellar Earnings, Poised to Break New Highs
- Wall Street Breakfast: Must-Know News
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »